Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04038151 · ClinicalTrials.gov registry record · NA

Intuitive Control of a Hybrid Prosthetic Leg During Ambulation

A NA study of Amputation, sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04038151: Recruiting NA study of Amputation, sponsored by Shirley Ryan AbilityLab.

NCT04038151 is a NA study of Amputation that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 20 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04038151, a NA study of Amputation, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The objective of this research is to determine the clinical benefits of an innovative and lightweight powered leg controlled using our intent recognition framework in laboratory and community environments.

Conditions Studied

Interventions

  • DEVICE Hybrid Leg
  • DEVICE Prescribed Passive Prosthesis

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-12-01
Est. Completion 2025-06-30
Phase NA
Shirley Ryan AbilityLab

138 total trials

What NCT04038151 shows while recruiting

NCT04038151 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Hybrid Leg is the first listed.

NCT04038151 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04038151 about?

NCT04038151 is a clinical study titled "Intuitive Control of a Hybrid Prosthetic Leg During Ambulation". The objective of this research is to determine the clinical benefits of an innovative and lightweight powered leg controlled using our intent recognition framework in laboratory and community environments.

What is the current status of trial NCT04038151?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2018-12-01. Estimated completion is 2025-06-30.

What conditions does trial NCT04038151 study?

This clinical trial studies the following conditions: Amputation.

What interventions are being tested in trial NCT04038151?

The interventions under investigation include: Hybrid Leg (DEVICE), Prescribed Passive Prosthesis (DEVICE).

Who is sponsoring clinical trial NCT04038151?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04038151 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04038151's enrollment target sits among peer trials

20 33rd of 65 higher than 25 of 65 other Amputation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04038151, the US trial registry maintained by the National Library of Medicine. NCT04038151 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.